Advertisement
Biotech Business – October 16, 2024
Abera Bioscience has been awarded a grant from Vinnova to advance the development of its pneumococcal vaccine, Ab-01.12, towards clinical trials.
Iceland – October 15, 2024
Scientists at deCODE genetics have discovered rare sequence variants, predicted to cause a loss of function of ITSN1, that are associated with a high risk of Parkinson‘s Disease.
Careers article – October 14, 2024
Sweden boasts a global reputation for cutting-edge research and innovation, but the country’s ambition to maintain its leading position as an innovation nation faces a significant challenge: securing and retaining top talent from abroad. Why then is the route to work permits for international professionals complex and lengthy?
Careers article – October 11, 2024
Besides her technical knowledge in clinical development and clinical operations, leading and managing company and regulatory agencies’ teams has been a core aspect of Margrethe Sørgaard’s career path.
In a new job – October 11, 2024
BerGenBio has announced that CEO, Martin Olin will be leaving the company to pursue other opportunities.
Advertisement
Advertisement
Clinical Trials – September 30, 2024
Cereno Scientific has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting.
Clinical Trials – September 19, 2024
Anocca will present its novel platform approach to therapeutic TCR discovery and preclinical data for its lead TCR-T cell therapy product at the European Society of Medical Oncology (ESMO) Congress 2024.
Clinical Trials – September 18, 2024
The results further demonstrate the potential for TILT-123 as an intravenous therapy.
Clinical Trials – September 18, 2024
The company has agreed with the investigators conducting the LUNGVAC trial to discontinue patient recruitment.
Clinical Trials – September 17, 2024
Medivir has presented positive, mature data from its ongoing phase 1b / 2a study of fostroxacitabine bralpamide (fostrox) + Lenvima in advanced liver cancer at the ESMO Congress in Barcelona, Spain.
Clinical Trials – September 14, 2024
Evaxion Biotech has announced new clinical phase 2 data for its lead compound EVX-01.
Financing – October 10, 2024
IRLAB Therapeutics has announced that dosing has been initiated in a Phase I clinical study of the drug candidate IRL757 in healthy adults aged 65 and older.
Agreement – October 7, 2024
AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical Group to advance the development of an early stage, novel small molecule Lipoprotein (a) (Lp(a)) disruptor that has the potential to offer additional benefits for patients with dyslipidaemia.
Agreement – October 7, 2024
The two companies have expanded their partnership to accelerate the development of the Dispersome technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules.
Financing – October 2, 2024
The Board of Directors of Spago Nanomedical has decided that the company’s resources will be focused on the development of Tumorad with the company’s primary priority being the execution of the ongoing clinical study Tumorad-01 with the candidate drug 177Lu-SN201.
Financing – October 2, 2024
The board of directors of Senzime has resolved on a directed share issue of a maximum of 13 873 000 shares at the subscription price of SEK 6.20 per share.
MedTech Business – September 20, 2024
For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility.
Biotech Business – October 4, 2024
Xbrane Biopharma has received scientific advice from the US Food and Drug Administration (FDA) on the development of its Opdivo biosimilar candidate Xdivane.
Biotech Business – September 27, 2024
Evaxion Biotech has entered into an option and license agreement with MSD for two preclinical vaccine candidates.
Biotech Business – September 24, 2024
The company has received a substantial investment from Kempestiftelserna.
Science – July 8, 2024
Unfortunately genes do matter when it comes to obesity, but knowledge about these genes and how they work are key to improving treatment and prevention.
Profiles in Science – June 18, 2024
Anna Falk, Head of Lund University’s Center for Advanced Therapies (LU-ATMP) and principal researcher of the Department of Neuroscience at Karolinska Institutet (KI) shares insights into her research, her multi-faceted job, and her vision for the future of neuroscience. Anna Falk is a molecular biologist with a PhD in neural stem cells and adult neurogenesis. […]
Science – September 20, 2023
An international team of scientists led by the University of Helsinki performed comprehensive mapping of structural alterations in cellular proteins during the aging process. In the study published in Molecular Cell, the team mapped structural alterations in cellular proteins during the aging process and, in the process, identifying new ways aging impacts how cells hum […]
Stryker
As a Territory Sales Manager being responsible for our Upper Extremities portfolio, you’ll help us deliver on our mission of making healthcare better by promoting and selling Stryker’s world-class Orthopaedic medical devices
Orifarm
The Company In Orifarm, they aim to bring healthy days by making modern healthcare a better deal for the people and the societies they serve. Everyone should have access to modern medicine. High costs or lack of access to pharmaceuticals should never impact possibility to receive treatment or relief and live a healthy life. Working […]
Ropox
The Company Giving people with disabilities a better life is core for Ropox. People with limited mobility deserve a life where they have the ability and freedom to safely take care of themselves.At the same time, their careers need optimum working conditions so they can spend their time where it is needed the most. Everything […]
Stryker
Are you ready to drive the market and new product development strategies for a cutting-edge global med tech product?
Haeger & Carlsson
On behalf of our customer, a Swedish biotech company in a very exciting phase of its development, Haeger&Carlsson recruits the company’s new CFO.
Stryker
As a Territory Sales Manager, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s Orthopaedic Instruments products in Göteborg & VGR region of Sweden.
In a new job – October 10, 2024
Sofia Mayans, who transitioned from her research to co-founding InfiCure Bio, is taking on a new role as Director of Business Development at Diamyd Medical in Umeå.
In a new job – October 7, 2024
Caroline Leksell Cooke has global experience in the software sector, with various positions in Google and, most recently, founded her own company focusing on digital transformation.
In a new job – October 4, 2024
Jens Ellrich, a German physician and medical scientist, brings experience in translational neuroscience, medical devices, biotechnology, pharmacology, and digital therapeutics.
Careers article – August 12, 2024
Getting back to work after a long and relaxing holiday can be quite hard, here is some advice to make things easier and make your return less stress-free. 1. Plan your return Most people focus on getting organized for departure, perhaps maximizing their time away and then comes home just the day before work begins. […]
Careers article – June 17, 2024
Samuli Ripatti has a background in mathematical statistics but his research has always been focused on applying and developing biostatistical methods to address scientific questions in medical and population genetics. Last year he was appointed Director of the Institute for Molecular Medicine in Finland (FIMM) and NLS asked him about his new role and his […]
Careers article – May 15, 2024
Ulrika Hammarström, CEO and Founder of Scandinavian CRO (SCRO) was recently awarded Entrepreneur of the Year in Uppsala, and NLS asked her about building successful teams, her leadership style and women in life sciences. This prize is awarded by jury to an entrepreneur who has performed above and beyond and whose company has demonstrated long-term […]
Profiles in Business – April 23, 2024
Despite being the co-founder of Ilya Pharma and co-director at the Science for Life Laboratory (SciLifeLab), Dr. Mia Phillipson, considers herself a scientist foremost, not an entrepreneur. “Most of all, I am a scientist. Yes, absolutely. This is my main occupation and the one in which I have the most expertise,” says Mia Phillipson, who […]
Business article – April 17, 2024
Personalized medicine, weight loss remedies and new treatments for widespread ailments are among the rising areas of high interest in the biotechnology and therapeutic arenas, according to executive chairman of Flerie Invest, Thomas Eldered. Thomas Eldered talked with Nordic Life Science about the Nordic and global life science financial landscapes and Flerie’s role in funding […]
Business – November 28, 2023
The previous founder and CEO of BioLamina has gone back to business development, and with his newly founded company he aims to redefine cell therapy development even further. Newly founded Alder Therapeutics is a preclinical phase stem cell therapy development company and, according to Kristian Tryggvason, co-founder and CEO, it is “the next big thing.” […]
This site uses cookies
